Found: 22
Select item for more details and to access through your institution.
An androgen receptor N-terminal domain antagonist for treating prostate cancer.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 7, p. 2948, doi. 10.1172/JCI66398
- By:
- Publication type:
- Article
Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy.
- Published in:
- Journal of Clinical Medicine, 2018, v. 7, n. 11, p. 444, doi. 10.3390/jcm7110444
- By:
- Publication type:
- Article
Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens.
- Published in:
- Research & Reports in Urology, 2018, v. 10, p. 23, doi. 10.2147/RRU.S157116
- By:
- Publication type:
- Article
Characterization of Niphatenones that Inhibit Androgen Receptor N-Terminal Domain.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107991
- By:
- Publication type:
- Article
FUS/TLS Is a Co-Activator of Androgen Receptor in Prostate Cancer Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024197
- By:
- Publication type:
- Article
Quantitative profiling of LNCaP prostate cancer cells using isotope-coded affinity tags and mass spectrometry.
- Published in:
- Proteomics, 2004, v. 4, n. 4, p. 1116, doi. 10.1002/pmic.200300649
- By:
- Publication type:
- Article
Amino‐terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer.
- Published in:
- Journal of Cellular Biochemistry, 2006, v. 98, n. 1, p. 36, doi. 10.1002/jcb.20802
- By:
- Publication type:
- Article
Differential Gene Expression Profiles between N-Terminal Domain and Ligand-Binding Domain Inhibitors of Androgen Receptor Reveal Ralaniten Induction of Metallothionein by a Mechanism Dependent on MTF1.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 386, doi. 10.3390/cancers14020386
- By:
- Publication type:
- Article
Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1991, doi. 10.3390/cancers12071991
- By:
- Publication type:
- Article
Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 10, p. 2455, doi. 10.1002/1878-0261.12770
- By:
- Publication type:
- Article
Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries.
- Published in:
- BMC Genomics, 2009, v. 10, p. 476, doi. 10.1186/1471-2164-10-476
- By:
- Publication type:
- Article
Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.
- Published in:
- BMC Genomics, 2006, v. 7, p. 246, doi. 10.1186/1471-2164-7-246
- By:
- Publication type:
- Article
Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01927-3
- By:
- Publication type:
- Article
LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer.
- Published in:
- BMC Medical Genomics, 2010, v. 3, p. 43, doi. 10.1186/1755-8794-3-43
- By:
- Publication type:
- Article
Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.
- Published in:
- Prostate, 2010, v. 70, n. 15, p. 1636, doi. 10.1002/pros.21199
- By:
- Publication type:
- Article
Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic.
- Published in:
- International Journal of Urology, 2016, v. 23, n. 8, p. 654, doi. 10.1111/iju.13137
- By:
- Publication type:
- Article
Isolation and characterization of castration-resistant prostate cancer LNCaP95 clones.
- Published in:
- Human Cell, 2021, v. 34, n. 1, p. 211, doi. 10.1007/s13577-020-00435-6
- By:
- Publication type:
- Article
Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 12, p. 1427, doi. 10.1634/theoncologist.2016-0161
- By:
- Publication type:
- Article
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1817, doi. 10.3390/ijms25031817
- By:
- Publication type:
- Article
Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0174134
- By:
- Publication type:
- Article
N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 3, p. 628, doi. 10.1016/j.molonc.2014.10.014
- By:
- Publication type:
- Article
Pursuit, Proof, Persistence and the Role of Champions and Mentors.
- Published in:
- AUANews, 2011, v. 16, n. 3, p. 26
- By:
- Publication type:
- Article